Prognostic Significance of Volumetric Parameters on Pretreatment FDG PET/CT in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab Therapy
TLG in intrahepatic HCC lesions was significantly associated with treatment response and served as an independent prognostic factor for PFS and OS. TLG could be a potential imaging biomarker for predicting clinical outcomes in patients with HCC receiving atezolizumab plus bevacizumab therapy.
Authors
- Su Jin Jang (ORCID: https://orcid.org/0000-0001-6103-6830)
- Chansik An (ORCID: https://orcid.org/0000-0002-0484-6658)
- Jeong Won Lee (ORCID: https://orcid.org/0000-0002-2697-3578)
- Hong Jae Chon (ORCID: https://orcid.org/0000-0002-6979-5812)
- Beodeul Kang (ORCID: https://orcid.org/0000-0001-5177-8937)
- Jung Sun Kim (ORCID: https://orcid.org/0000-0003-1132-5217)
- Sang Mi Lee (ORCID: https://orcid.org/0000-0002-7943-3807)
Institutions
- Soonchunhyang University (KR)
- CHA University Bundang Medical Center (KR)
- CHA University (KR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1097/rlu.0000000000005896
- Citations
- 4
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 5.29